BioVie Inc.
NASDAQ:BIVI
2.77 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.229 | 0.267 | 0.237 | 0.229 | 0.229 | 0.229 | 0.229 | 0.229 | 0.051 | 0 | 0 | 0 |
| Gross Profit
| -0.229 | -0.267 | -0.237 | -0.229 | -0.229 | -0.229 | -0.229 | -0.229 | -0.051 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 23.1 | 33.3 | 17.258 | 133.188 | 1.151 | 1.008 | 0.371 | 0.466 | 0.038 | 0.004 | 0.049 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 1.259 | 1.772 | 0.858 | 0.343 | 0.229 | 0.273 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.85 | 11.552 | 9.765 | 4.637 | 1.313 | 1.259 | 1.772 | 0.858 | 0.343 | 0.229 | 0.273 | 0.07 |
| Other Expenses
| 0.229 | 229.377 | 0.229 | 0.229 | 0.229 | 0.229 | 0.229 | 0.229 | 0.051 | 0.213 | 0.247 | 0 |
| Operating Expenses
| 32.18 | 45.08 | 27.253 | 138.054 | 2.693 | 2.497 | 2.372 | 1.554 | 0.432 | 0.233 | 0.322 | 0.07 |
| Operating Income
| -32.18 | -45.08 | -27.253 | -138.054 | -2.693 | -2.497 | -2.372 | -1.554 | -0.432 | -0.233 | -0.322 | -0.07 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.059 | -1.437 | 1.169 | 7.805 | -13.984 | 0.052 | -0.041 | 0.223 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -32.121 | -50.256 | -26.084 | -130.249 | -16.677 | -2.444 | -2.413 | -1.331 | -0.432 | -0.233 | -0.322 | -0.07 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.229 | 4.3 | -3.287 | 0.559 | 4.772 | -0.051 | -0 | -0.223 | -0 | -0 | -0 | 0 |
| Net Income
| -32.121 | -50.256 | -26.084 | -183.847 | -33.776 | -2.493 | -2.434 | -1.331 | -0.432 | -0.233 | -0.322 | -0.07 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -7.31 | -15.47 | -10.58 | -148.23 | -68.52 | -9.82 | -31.77 | -18.61 | -6.19 | -3.34 | -4.62 | 0 |
| EPS Diluted
| -7.11 | -15.5 | -10.6 | -148.23 | -68.52 | -9.82 | -31.77 | -18.61 | -6.19 | -3.34 | -4.62 | 0 |
| EBITDA
| -31.95 | -44.289 | -26.98 | -137.803 | -2.463 | -2.266 | -2.143 | -1.324 | -0.381 | -0.233 | -0.322 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |